Kala Pharmaceuticals
KALA
$6.75
Share price
-2.81%
Change (1 day)
-55.53%
Change (1 year)
Categories
Kala Pharmaceuticals (KALA) - P/B ratio
P/B ratio as of May 2024 : 2.54
According to Kala Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 2.54.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Kala Pharmaceuticals - P/B ratio (from 2017 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 2.51 | -21.68% |
| 2022-12-31 | 3.21 | -31.99% |
| 2021-12-31 | 4.72 | 18.07% |
| 2020-12-31 | 3.99 | -10.93% |
| 2019-12-31 | 4.48 | 184.31% |
| 2018-12-31 | 1.58 | -68.8% |
| 2017-12-31 | 5.06 | |
| 2016-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 0.6522 | -74.27% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 1.96 | -22.74% | 🇺🇸 USA |